A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma

Table 1 Patient and tumour characteristics

	HCV/HCC	NASH/HCC	P value
	n = 64	n = 17
Age at transplant (mean ± SD)	52.6 ± 5.8	58.6 ± 4.2	< 0.001
Gender (% male)	94%	94%	1.000
Donor source (DBD/DCD/LD)	56/8/0	16/0/1	NA
AFP (mean ± SD)	93.1 ± 204.4	20.3 ± 34.0	0.149
Number of tumours (mean ± SD)	1.59 ± 0.81	1.64 ± 0.75	0.819
Cumulative size of tumours (mean ± SD)	3.98 ± 2.4	3.27 ± 2.1	0.270
Vascular invasion	23.40%	6.30%	0.002
Poorly differentiated	4.70%	0%	< 0.001

AFP: α-feto-protein; DBD: Donation after brain death; DCD: Donation after circulatory death; LD: Living donor; HCC: Hepatocellular carcinoma; HCV: Hepatitic C virus; NASH: Non-alcoholic steatohepatitis; NA: Not available.